Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Conditions: HIV Infections; Tuberculosis Interventions: Other: Placebo; Drug: Dolutegravir 50 mg Sponsors: University of Cape Town; Wellcome Trust; Medecins Sans Frontieres, Netherlands Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials